DEMO Pharmaceutical Industry S.A. today was informed by the UK regulatory authorities that its pan-european registration of its Meropenem injection product (Merozan) in six of the biggest markets in Europe has reached its Day 105.  It is expected that Merozan will be launched in Europe during the frst quarter of 2010.